T.i.d. radiotherapy with or without alternating chemotherapy in patients with a locally advanced squamous cell carcinoma of the head or neck: An analysis of late toxicity;Radiothérapie trifractionnée accélérée seule ou alternée avec la chimiothérapie chez des patients souffrant d'un cancer localement évolué de la sphère ORL: Analyse de la toxicité tardive

Cancer/Radiotherapie

Volumn 5, Issue 2, 2001, Pages 130-137

  Laszlo, A ^a,b   Rosset, A ^a   Hermann, F ^b   Ozsahin, M ^a   Zouhair, A ^a   Mirimanoff, R O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Chemotherapy; Head and neck cancer; Late complications; Radiation therapy; Unconventional fractionation

Indexed keywords

CISPLATIN; FLUOROURACIL; VINDESINE;

ARTICLE; BONE NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RATING SCALE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0035041741     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(01)00085-3     Document Type: Article

References (21)

1. Complications tardives des associations radio-chimiothérapeutiques: Aspects fondamentaux et expérience clinique
2. Psychological distress in head and neck cancer after curative treatment
3. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
4. Lhermitte's sign: Incidence and treatment variables influencing risk after irradiation of the cervical spine
5. Randomized phase I/II trials of two variants of accelerated fractionated radiotherapy regiments for advanced head and neck cancer: Results of RTOG
6. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13
7. Radionecrosis of mandibule: A retrospective analysis of the incidence and risk
8. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
9. Hyperfractionated radiotherapy and simultaneous cisplatin for stage III and IV carcinomas of head and neck. Long-term results including functional outcome
10. Radiation myelopathy
11. Pathological features of cerebral radiation necrosis. Part I
12. Rapidly alterning chemotherapy and hyperfractioned radiotherapy in the managment of localy advanced head and neck carcinoma: Four-year results of a phase I/II study
13. The oral cavity and oropharynx
14. About tolerance and quality. An important notice to all oncologists
15. Comment coder la toxicité tardive en radiothérapie
16. EORTC late effects working group: Late effects toxicity scoring: The SOMA scale
17. RTOG late effects working group: Overview of late effects normal tissues(LENT) scoring system
18. Mesure de la qualité de vie en cancérologie
19. Time-dose factor in radiotherapy: A review of human data
20. Accelerated versus conventional fractionation. The degree of incomplete repair in human skin with a four-hour-fraction interval study after post-mastectomay irradiation
21. Dose fractionation and volume effects in normal tissue and tumor